Financhill
Buy
75

LHX Quote, Financials, Valuation and Earnings

Last price:
$298.24
Seasonality move :
9.42%
Day range:
$297.82 - $299.83
52-week range:
$193.09 - $308.12
Dividend yield:
1.61%
P/E ratio:
31.98x
P/S ratio:
2.59x
P/B ratio:
2.85x
Volume:
1.1M
Avg. volume:
1.1M
1-year change:
39.76%
Market cap:
$55.7B
Revenue:
$21.3B
EPS (TTM):
$9.31

Earnings Data

Next earnings date for LHX
Feb 05
2026
Most recent earnings per share
$2.46
Missed by $0.11
(Oct 30/2025)
Consensus Estimate
$2.57
(Oct 30/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

LHX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/05/2026 Q4 $5.8B -- -- $2.78 --
10/30/2025 Q3 $5.5B $5.7B $2.46 $2.57 -$0.11
07/24/2025 Q2 $5.3B $5.4B $2.44 $2.50 -$0.06
04/24/2025 Q1 $5.2B $5.1B $2.04 $2.32 -$0.28
01/30/2025 Q4 $5.5B $5.5B $2.38 $3.42 -$1.04
10/24/2024 Q3 $5.3B $5.3B $2.10 $3.26 -$1.17
07/25/2024 Q2 $5.3B $5.3B $1.92 $3.18 -$1.26
04/25/2024 Q1 $5.1B $5.2B $1.48 $2.91 -$1.43
01/25/2024 Q4 $5.3B $5.3B $0.83 $3.31 -$2.48
10/26/2023 Q3 $4.9B $4.9B $2.01 $3.03 -$1.02
07/26/2023 Q2 -- $4.7B $1.84 -- --
04/27/2023 Q1 -- $4.5B $1.76 -- --
01/26/2023 Q4 -- $4.6B $2.17 -- --
10/28/2022 Q3 -- $4.2B -$1.57 -- --
07/28/2022 Q2 -- $4.1B $2.43 -- --
04/29/2022 Q1 -- $4.1B $2.43 -- --
01/31/2022 Q4 -- $4.4B $2.46 -- --
10/29/2021 Q3 -- $4.2B $2.39 -- --
08/03/2021 Q2 -- $4.7B $2.01 -- --
04/30/2021 Q1 -- $4.6B $2.24 -- --
01/29/2021 Q4 -- $4.7B $0.91 -- --
10/30/2020 Q3 -- $4.5B $1.98 -- --
07/31/2020 Q2 -- $4.4B $1.30 -- --
05/05/2020 Q1 -- $4.6B $0.99 -- --
02/04/2020 Q4 -- $4.8B $1.80 -- --
10/30/2019 Q3 -- $4.4B $1.90 -- --
07/31/2019 Q2 -- $1.9B $2.21 -- --
05/01/2019 Q1 -- $7.4B $4.61 -- --
01/29/2019 Q4 -- $1.7B $1.87 -- --
10/14/2018 Q3 -- $1.5B $1.77 -- --
07/31/2018 Q2 -- $1.7B $1.78 -- --
05/02/2018 Q1 -- $1.6B $1.65 -- --
01/30/2018 Q4 -- $1.5B $1.08 -- --
10/31/2017 Q3 -- $1.4B $1.33 -- --
08/01/2017 Q2 -- $1.5B $1.14 -- --
05/03/2017 Q1 -- $1.5B $0.63 -- --
02/02/2017 Q4 -- $1.4B $1.45 -- --
11/01/2016 Q3 -- $1.4B $1.29 -- --
08/02/2016 Q2 -- $1.5B $1.28 -- --
05/03/2016 Q1 -- $1.6B $1.33 -- --
02/02/2016 Q4 -- $1.7B -$1.06 -- --

L3Harris Technologies, Inc. Earnings Questions

  • How Much did L3Harris Technologies, Inc. Generate in Revenue Last Quarter?

    L3Harris Technologies, Inc. reported $5.7B worth of top line sales in its most recent quarter.

  • Did L3Harris Technologies, Inc. Beat Earnings Last Quarter?

    L3Harris Technologies, Inc. announced earnings per share of $2.46 which represents a miss of analyst forecast a $2.57 per share.

  • Is L3Harris Technologies, Inc. Profitable?

    L3Harris Technologies, Inc. reported $1.3B that represents $7.00 per share over the last quarter.

  • What is the Analyst Consensus for L3Harris Technologies, Inc. EPS Next Year?

    L3Harris Technologies, Inc.'s earnings are forecast to grow from $7.88 per share to $13.07 per share next year representing an increase of 35.35%.

  • When is L3Harris Technologies, Inc.'s Earnings Date?

    L3Harris Technologies, Inc.'s next earnings date is February 5, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock